Israel - English - Ministry of Health

csl behring ltd., israel - c - 1 esterase inhibitor human - powder for solution for inj/inf - c - 1 esterase inhibitor human 500 iu/vial - c1- inhibitor,plasma derived - c1- inhibitor,plasma derived - hereditary angioedema type i and ii (hae).treatment and pre-procedure (prior to oral, dental, and upper respiratory tract procedures) prevention of acute episodes

European Union - English - EMA (European Medicines Agency)

takeda manufacturing austria ag - c1 inhibitor (human) - angioedemas, hereditary - c1-inhibitor, plasma derived, drugs used in hereditary angioedema - treatment and pre-procedure prevention of angioedema attacks in adults, adolescents and children (2 years old and above) with hereditary angioedema (hae).routine prevention of angioedema attacks in adults, adolescents and children (6 years old and above) with severe and recurrent attacks of hereditary angioedema (hae), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - c1 esterase inhibitor, quantity: 500 u - injection, solution - excipient ingredients: water for injections - treatment and pre-procedure prevention of angioedema attacks in adults and adolescents with c1 inhibitor deficiency. routine prevention of angioedema attacks in adults and adolescents with frequent attacks of hereditary angioedema (hae), who are intolerant to or insufficiently protected by oral therapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

csl behring gmbh - c1 esterase inhibitor (human) - powder and solvent for solution for injection - 1500 international unit(s) - c1-inhibitor, plasma derived

Ireland - English - HPRA (Health Products Regulatory Authority)

csl behring gmbh - c1 esterase inhibitor (human) - powder and solvent for solution for injection - 2000 international unit(s) - c1-inhibitor, plasma derived

Ireland - English - HPRA (Health Products Regulatory Authority)

csl behring gmbh - c1 esterase inhibitor (human) - powder and solvent for solution for injection - 3000 international unit(s) - c1-inhibitor, plasma derived

Ireland - English - HPRA (Health Products Regulatory Authority)

csl behring gmbh - c1 esterase inhibitor (human) - powder and solvent for solution for injection - 500 international unit(s) - c1-inhibitor, plasma derived

Malta - English - Medicines Authority

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - c, inhibitor, plasma derived - powder and solvent for solution for infusion or injection - c1-inhibitor, plasma derived 500 iu - other hematological agents

Canada - English - Health Canada

csl behring canada inc - c1 esterase inhibitor (human) - kit - 500unit - c1 esterase inhibitor (human) 500unit - complement inhibitors

Canada - English - Health Canada

csl behring canada inc - c1 esterase inhibitor (human) - kit - 1500unit - c1 esterase inhibitor (human) 1500unit - complement inhibitors